Company intelligence / Profile preview

IotaChem

Seattle, Washington, United States

Ownership: Private
Development stage: Other

Overview

IotaChem is a biotechnology and contract research organization (CRO) that specializes in the design and synthesis of complex small molecules for drug discovery and development. The company provides high-quality chemical synthesis services, including the production of building blocks, scaffolds, and reference compounds to support pharmaceutical and biotech partners. IotaChem leverages its expertise in medicinal chemistry to accelerate the lead optimization process for its clients. By focusing on precision and efficiency in chemical synthesis, the company serves as a critical partner in the early-stage development of novel therapeutic agents.

Modalities: Small molecule
Industry: Drug Discovery Services

Beyond the preview

Go deeper on IotaChem.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on IotaChem.

Explore the full profile